Skip to main content
logo
Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.020
+0.052 (5.42%)
Aug 5, 2026, 11:33 AM EDT - Market open

Tiziana Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.43-16.75-17.24-15.4-26.66
Depreciation & Amortization
0.230.120.10.050.14
Stock-Based Compensation
4.435.742.26-1.416.03
Other Adjustments
-2.159.910.77-1.7-0.5
Change in Receivables
-0.69-1.39-1.44-0.160.43
Changes in Accounts Payable
3.220.84-0.14-1.01-1.2
Changes in Unearned Revenue
0.53----
Operating Cash Flow
-12.85-1.53-15.7-19.62-21.76
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.02-0.02---0.02
Purchases of Investments
--0.05-1.25-4-
Proceeds from Sale of Investments
3.06----
Other Investing Activities
----0.15
Investing Cash Flow
3.04-0.07-1.25-40.13

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
10.24.650.16-0.13
Net Common Stock Issued (Repurchased)
10.24.650.16-0.13
Other Financing Activities
-0.2-0.14-0.12-0.06-0.15
Financing Cash Flow
10.014.510.04-0.06-0.02

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.08-0.37-0.03-0.4-1.98
Net Cash Flow
0.22.91-16.91-23.67-21.66

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12.87-1.55-15.7-19.62-21.78
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.54-0.07-0.77-0.97-1.11
Levered Free Cash Flow
-14.46-10.92-17.73-16.35-24.5
Unlevered Free Cash Flow
-17.17-14.85-18.03-15.54-25.13
SEC Filings: 10-K · 10-Q